EXANE DERIVATIVES - QIAGEN NV ownership

QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 217 filers reported holding QIAGEN NV in Q3 2017. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of QIAGEN NV
ValueSharesWeighting
Q2 2022$772,584,00016,639
+11.8%
0.44%
Q1 2022$014,886
-47.9%
0.00%
Q4 2021$0
-100.0%
28,548
-47.3%
0.00%
Q3 2021$1,00054,157
+53.3%
0.00%
Q2 2021$0
-100.0%
35,328
-9.7%
0.00%
-100.0%
Q1 2021$1,091,671,000
-12.4%
39,103
-8.4%
0.31%
-15.0%
Q4 2020$1,246,815,000
-40.5%
42,673
-43.2%
0.37%
-39.4%
Q3 2020$2,093,753,000
+451.7%
75,105
+427.6%
0.61%
+500.0%
Q2 2020$379,537,000
+1046.4%
14,234
+344.8%
0.10%
+1583.3%
Q3 2018$33,107,000
-70.5%
3,200
-11.1%
0.01%
-66.7%
Q2 2018$112,056,000
+635.8%
3,600
+599.0%
0.02%
+500.0%
Q1 2018$15,229,000
-91.7%
515
-89.9%
0.00%
-90.6%
Q4 2017$183,193,000
+135.5%
5,105
+297.3%
0.03%
+113.3%
Q3 2017$77,790,000
-94.5%
1,285
-97.0%
0.02%
-95.0%
Q2 2017$1,405,289,000
-41.8%
42,563
-48.7%
0.30%
-44.7%
Q1 2017$2,412,966,00082,9440.55%
Other shareholders
QIAGEN NV shareholders Q3 2017
NameSharesValueWeighting ↓
Kite Lake Capital Management (UK) LLP 1,080,000$52,585,00033.78%
SYCOMORE ASSET MANAGEMENT 430,536$20,822,0004.03%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 8,215,122$397,895,0003.96%
Grandeur Peak Global Advisors, LLC 834,208$40,618,0002.21%
Premier Fund Managers Ltd 1,109,129$53,325,0002.06%
Eversept Partners, LP 454,721$22,140,3651.66%
Chescapmanager LLC 280,000$13,633,0001.45%
HealthCor Management, L.P. 838,414$40,822,0001.44%
Bank of Italy 591,025$28,599,0001.30%
swisspartners Ltd. 31,000$1,503,0001.22%
View complete list of QIAGEN NV shareholders